Welcome to LookChem.com Sign In|Join Free

CAS

  • or

21753-19-5

Post Buying Request

21753-19-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21753-19-5 Usage

Description

Nα-Tosyl-D-α,β-diaminopropionic Acid, with the CAS number 21753-19-5, is a white powder compound that is primarily utilized in the field of organic synthesis. It serves as a valuable building block for the creation of various complex organic molecules and plays a significant role in the development of novel chemical entities.

Uses

Used in Organic Synthesis:
Nα-Tosyl-D-α,β-diaminopropionic Acid is used as a synthetic building block for the development of complex organic molecules. Its unique structure and reactivity make it a versatile component in the synthesis of a wide range of compounds, including pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, Nα-Tosyl-D-α,β-diaminopropionic Acid is used as a key intermediate in the synthesis of various therapeutic agents. Its incorporation into drug molecules can enhance their pharmacological properties, such as potency, selectivity, and bioavailability, leading to the development of more effective treatments for a variety of diseases.
Used in Agrochemical Industry:
Nα-Tosyl-D-α,β-diaminopropionic Acid also finds application in the agrochemical industry, where it is employed in the synthesis of novel pesticides and other crop protection agents. Its unique chemical properties allow for the creation of innovative molecules with improved efficacy and selectivity, contributing to more sustainable and environmentally friendly agricultural practices.
Used in Research and Development:
In the field of research and development, Nα-Tosyl-D-α,β-diaminopropionic Acid serves as an important tool for chemists and biologists working on the discovery and optimization of new molecules with potential applications in various industries. Its availability and reactivity make it a valuable asset in the pursuit of scientific advancements and the development of innovative solutions to complex problems.

Check Digit Verification of cas no

The CAS Registry Mumber 21753-19-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,7,5 and 3 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 21753-19:
(7*2)+(6*1)+(5*7)+(4*5)+(3*3)+(2*1)+(1*9)=95
95 % 10 = 5
So 21753-19-5 is a valid CAS Registry Number.
InChI:InChI=1/C10H14N2O4S/c1-7-2-4-8(5-3-7)17(15,16)12-9(6-11)10(13)14/h2-5,9,12H,6,11H2,1H3,(H,13,14)

21753-19-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Nα-Tosyl-L-α,β-diaminopropionic Acid

1.2 Other means of identification

Product number -
Other names 3-amino-2-[(4-methylphenyl)sulfonylamino]propanoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21753-19-5 SDS

21753-19-5Relevant articles and documents

Development of the Hofmann rearrangement of Nα-tosylasparagine through calorimetric and NMR analysis

Amato, Joseph S.,Bagner, Carl,Cvetovich, Raymond J.,Gomolka, Sue,Hartner Jr., Frederick W.,Reamer, Robert

, p. 9533 - 9534 (1998)

-

A highly convergent synthesis of a fibrinogen receptor antagonist

Hartner, Frederick W.,Cvetovich, Raymond J.,Tsay, Fuh-Rong,Amato, Joseph S.,Pipik, Brenda,Grabowski, Edward J. J.,Reider, Paul J.

, p. 7751 - 7755 (2007/10/03)

A practical multikilogram synthesis of 2(S)-[(p-toluenesulfonyl)amino]- 3-[[[5,6,7,8-tetrahydro-4-oxo-5-[2-(piperidin-4-yl)ethyl]-4H-pyrazolo[1,5- α][1,4]diazepin-2-yl]carbonyl]amino]propionic acid pentahydrate (1), an oral fibrinogen receptor antagonist, is described. The nine-step convergent process, which afforded 1 in 37% overall yield, included pyrazole 5a and N- tosylaminoalanine 16 as key fragments. Pyrazole 5a was obtained from pyrazole-3,5-dicarboxylic acid by esterification with MeOH, alkylation/cyclization with 3-bromopropylamine, and Michael addition with 4- vinylpyridine. N-Tosylaminoalanine 16 was prepared by tosylation of asparagine, Hofmann reaction, and benzyl esterification. Saponification of pyrazole 5a, coupling of the acid with N-tosylaminoalanine 16, and Pd- catalyzed hydrogenolysis and pyridine reduction completed the synthesis.

Asymmetric synthesis of (R)-6-amino-1-methyl-4-(3-methyl- benzyl)hexahydro-1H-1,4-diazepine from L-asparagine

Kato,Harada,Morie

, p. 1469 - 1478 (2007/10/03)

An efficient asymmetric synthesis of (R)-6-amino-1-methyl-4-(3- methylbenzyl)hexahydro-1H-1,4-diazepine [(R)-2] which serves as the amine part of (R)-1, a potent and selective 5-HT3 receptor antagonist, is described. Formation of the hexahydro-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 21753-19-5